Digital Rectal Examination News and Research

RSS

New study challenges role of rectal exam in prostate cancer screening

A study by the Comprehensive Cancer Center Vienna of MedUni Vienna and Vienna General Hospital has taken a closer look at the effectiveness of common examination methods for the early detection of prostate cancer.

19 Jan 2024

Nomogram helps predict anal cancer risk in HIV patients

Both cervical and anal cancer are caused by human papillomavirus. Both diseases also share a common precursor: abnormal cells known as high-grade squamous intraepithelial lesions (HSIL).

1 Jul 2022

New ultrasound scan can detect prostate cancer cases with good accuracy

An ultrasound scan can be used to detect cases of prostate cancer, according to new research.

28 Feb 2022

Prostate cancer urine test identifies men who can safely avoid immediate treatment

Researchers at the University of East Anglia have shown that a prostate cancer urine test can identify men at 'intermediate risk' who can safely avoid immediate treatment and benefit from 'active surveillance' instead.

2 Nov 2021

Thousands of men to trial new home test kit for prostate cancer

Thousands of men worldwide are to receive a home test kit for prostate cancer – thanks to pioneering research from the University of East Anglia and the Norfolk and Norwich University Hospital (NNUH).

30 Apr 2021

New urine test for prostate cancer shows aggressiveness of the disease

Researchers from the University of East Anglia have developed a new urine test for prostate cancer which also shows how aggressive the disease is.

27 Apr 2021

HKBU and CUHK jointly develop Spermine Risk Score for diagnosis of prostate cancer

Researchers from Hong Kong Baptist University and the Faculty of Medicine at The Chinese University of Hong Kong have jointly developed the Spermine Risk Score which, coupled with the use of a urine test, provides a non-invasive and more reliable method for the diagnosis of prostate cancer.

8 Feb 2021

Study: New biopsy methods can help improve benefit-harm ratio of PSA screening

The benefit of population-based PSA screening for men with an average risk of prostate cancer does not outweigh the harm caused.

29 May 2020

Urine test could help men avoid unnecessary prostate cancer biopsies

Unnecessary prostate cancer biopsies could be reduced by 60 percent thanks to new research from the University of East Anglia.

9 Mar 2020

'Watch-and-Wait' strategy may help rectal cancer patients to safely evade surgery

A team of doctors and scientists from the Champalimaud Clinical Centre in Lisbon, Portugal, and the Netherlands Cancer Institute in Amsterdam, has shown that patients with "low" rectal cancer (that is, very close to the anus) who show no sign of their tumors after a course of radio- and chemotherapy can safely choose to postpone invasive and complication-prone surgical procedures.

6 Feb 2020

Simple urine test at home could revolutionize diagnosis of prostate cancer

A simple urine test under development for prostate cancer detection can now use urine samples collected at home - according to new research from University of East Anglia and the Norfolk and Norwich University Hospital.

28 Nov 2019

Home urine testing kit for prostate cancer could come soon

A new study from the University of East Anglia and the Norfolk and Norwich University Hospital may lead to people being able to test for prostate cancer from home, using urine samples. The study, which was published in the journal BioTechniques, describes a simple home urine collection test which can detect aggressive prostate cancer, and providing information on whether it requires to be treated, up to 5 years earlier than the comparable diagnostic methods of today.

28 Nov 2019

New prostate cancer test could bring an end to unnecessary biopsies

Researchers have developed a new urine test to diagnose aggressive forms of prostate cancer, which could mean an end to the unnecessary treatment of men with non-aggressive cancers.

26 Jun 2019

Study finds limited data to support effectiveness of digital rectal exam in primary care

Although the digital rectal exam is widely used in primary care to screen for prostate cancer, a new study finds limited data to support its effectiveness.

14 Mar 2018

Prostate cancer screening reduces cancer deaths finds new analysis

There has been much debate regarding the utility of prostate cancer screening in reducing the rates of deaths due to this cancer among men. While the ERSPC (European Randomized Study of Screening for Prostate Cancer) suggests that screening reduced prostate cancer deaths, the PLCO (Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial) found that regular screening does not reduce the cancer death rates in prostate cancer. Researchers thus looked at the actual picture as to which of these – ERSPC or PLCO are correct.

5 Sep 2017

African American men with prostate cancer have significantly lower PSA density than Caucasian men

A new study published in The Journal of Urology revealed that African American men with Gleason score 3+3=6 prostate cancer (PCa) produce less prostate specific antigen (PSA) and have significantly lower PSA density (PSAD) than Caucasian men. These findings could have important implications when selecting patients for inclusion in active PCa surveillance programs.

5 Jan 2016

New studies to improve prostate cancer detection to be presented at AUA annual meeting

Five new studies evaluating the use of imaging and urine-based biomarkers as ways to improve prostate cancer detection will be presented during the 110th Annual Scientific Meeting of the American Urological Association (AUA).

18 May 2015

Study: Targeted biopsy technique better than standard biopsy at detecting high-risk prostate cancer

Among men undergoing biopsy for suspected prostate cancer, targeted magnetic resonance/ultrasound fusion biopsy, compared with a standard biopsy technique, was associated with increased detection of high-risk prostate cancer and decreased detection of low-risk prostate cancer, according to a study in the January 27 issue of JAMA.

28 Jan 2015

BRCA2 mutations herald poor prognosis in screen-detected prostate cancer

Among men with prostate cancer detected on screening, survival among those with a mutation in the BRCA2 gene is much poorer than in those without such a mutation, researchers report.

18 Aug 2014

Beckman announces national availability of Prostate Health Index

Beckman Coulter Diagnostics, a global leader in prostate cancer diagnostics, announces national availability of the Prostate Health Index (phi)*, a simple, non‐invasive blood test that is three times more specific in detecting prostate cancer1 than PSA (prostate‐specific antigen).

22 Jul 2014